Two Drugs Offer Hope Against a Tough-to-Treat Prostate Cancer

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.



Sat Mar 03, 2018 02:25 PM

tried these type drugs --seem to last approx 17 to 36 months--very expensive also.

Sun Mar 04, 2018 04:04 PM

these drugs above will only respond to androgen dependent driven prostate cancerous cells.  Bigman1

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.